BRISTOL MYERS SQUIBB CO (BMY) Options Risk Score

Run a full BMY options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on BRISTOL MYERS SQUIBB CO (BMY) right now?

For a 4-week expiry, BRISTOL MYERS SQUIBB CO (BMY) carries an options catalyst-risk score of 59 out of 100 (MEDIUM). That score is driven by 4 recent news items, 10 active legal filings and 18 clinical-trial catalysts falling inside the 4-week window. MEDIUM covers 45 to 69: there is something on BMY's calendar worth reading before you pick an expiry, without it dominating the trade. Direction is not part of what the score measures.

BMY shows an IV Rank of 66, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 36%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BMY.

BMY does not report again until 2026-10-29, so near-dated expiries avoid it.

BRISTOL MYERS SQUIBB CO (BMY) current implied volatility and IV Rank

BMY is trading at an IV Rank of 66 with implied volatility around 36%, alongside a TickerRisk options-risk score of 59/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

Unsure how to act on this? What IV Rank is worth selling at →

BRISTOL MYERS SQUIBB CO (BMY) next earnings date — 2026-10-29

The next report for BMY is 2026-10-29 — about 8 days away, which sits beyond the nearest expiry. Nothing scheduled is threatening a near-dated position today, though premium on longer expiries will start to reflect the date as it approaches. BMY's IV Rank is currently 66.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer